Transplant Co-Morbidity Superpanel
Gene: SLCO1B1
It is involved in guidelines for statins including CPIC guidelines for atorvastatin, simvastatin, and rosuvastatin. It is also implicated in a range of pharmacogenomic responses: https://www.pharmgkb.org/gene/PA134865839
Rotor type hyperbilirubinemia (HBLRR) is caused by digenic inheritance of homozygous mutations in the SLCO1B1 (MIM# 604843) and SLCO1B3 (MIM# 605495) genes. Van de Steeg et al. (2012) (PMID: 22232210) suggested that individuals with Rotor syndrome may also be at increased risk for drug toxicity, since these proteins are involved in the clearance of drug conjugates. SLCO1B1 single nucleotide polymorphisms and haplotypes have been implicated in altered pharmacokinetic handling and pharmacodynamic response
The solute carrier organic anion transporter family member 1B1 (SLCO1B1) gene encodes for a membrane-bound sodium-independent organic anion transporter protein (OATP1B1). OATP1B1 mediates active transport of many endogenous substrates, such as bile acids, xenobiotic compounds, and a wide panel of pharmaceutical compounds. (PMID: 19952871)
SLCO1B1 variants are known to be a strong predictor of statin-associated muscle symptoms (SAMS) risk with simvastatin (PMID: 5152405).
Allelic variants of SLCO1B1 and ABCB1 predict the lipid-lowering efficacy of atorvastatin (PMID:35968761).
Sources: Expert listCreated: 25 Aug 2023, 12:15 a.m.
Mode of inheritance
Other
Phenotypes
Hyperbilirubinemia, Rotor type, digenic MIM# 237450
Publications
Gene: slco1b1 has been classified as Green List (High Evidence).
Gene: slco1b1 has been classified as Green List (High Evidence).
gene: SLCO1B1 was added gene: SLCO1B1 was added to Transplant Co-Morbidity Superpanel. Sources: Expert list Mode of inheritance for gene: SLCO1B1 was set to Other Publications for gene: SLCO1B1 were set to 19952871; 5152405; 35968761 Phenotypes for gene: SLCO1B1 were set to Hyperbilirubinemia, Rotor type, digenic MIM# 237450 Review for gene: SLCO1B1 was set to GREEN